How New Water Filters And AI Tools At DuPont (DD) Have Changed Its Investment Story Sasha Jovanovic Fri, November 13, 2026 at 6:11 AM EST 4 min read DD 0.00% MSFT -1.68% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
DuPont de Nemours has expanded its water treatment portfolio with four new high flow Electrodeionization modules and has also formed a collaboration with Microsoft and NobleAI to apply AI tools in research and development.
The combination of higher capacity water purification hardware and AI supported lab work directly targets productivity, cost efficiency and time to market across DuPont de Nemours' focused industrial portfolio.
We will look at how DuPont de Nemours' investment narrative is shaped by this AI collaboration as a test case.
Spot emerging themes around AI infrastructure and industrial water by comparing DuPont de Nemours with 53 AI infrastructure stocks that are already positioning for the next wave of data center and fabrication demand.
To own DuPont de Nemours, you need to be on board with a portfolio centered on Healthcare & Water Technologies and Diversified Industrials, plus a business system that leans heavily on productivity and R&D. The analyst consensus narrative on Simply Wall St focuses on this setup, together with high free cash flow conversion and active capital returns.
The short term swing factor is execution on cost and pricing in the face of about US$90 million of oil and gas input inflation and slower water project timing in the Middle East. PFAS related liabilities and any new settlements remain a key risk that could absorb cash that might otherwise go to growth or buybacks.
The clearest recent read-through for this story is the Q3 2026 result. DuPont de Nemours reported US$1,868 million of quarterly sales and net income of US$123 million, with the company profitable again over the first nine months and earnings per share from continuing operations above US$3 on a basic basis.
That update came with raised full year 2026 sales guidance to about US$7,190 million and a Q4 sales outlook around US$1,825 million. For a shareholder, the interest is in how this sits alongside new AI collaborations and expanded EDI capacity as potential supports for productivity, margin resilience and future Healthcare & Water earnings power, while still respecting the environmental and pricing risks already on the table.
DuPont de Nemours' current analyst story lines up around revenues of US$8.1b and earnings of US$985.6m by 2029, built on a 4.6% yearly top line growth assumption and an earnings increase of about US$597.6m from US$388.0m today.
Discover why DuPont de Nemours' fair value indicates an 11% potential upside to its current price that may not last much longer.
One alternate view focuses on DuPont de Nemours as a beneficiary of developments in AI and water purity. Those bullish analysts were already modeling revenue of about US$8.2b and earnings near US$1.1b by 2029, a step above the consensus. You can treat the new AI collaboration and high flow EDI launch as real world tests of that optimism, then compare several narratives before deciding what fits your own expectations.
Explore 3 other DuPont de Nemours fair value estimates, including one that suggests up to 40% potential upside from the current price.
Don't just follow the ticker; dig into the data and build a conviction that's truly your own.
A great starting point for your DuPont de Nemours research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
See our latest analysis for DuPont de Nemours. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate DuPont de Nemours' overall financial health at a glance.
If the DuPont de Nemours story has you thinking about where else productivity, balance sheet strength and steady cash generation might pay off, it can help to scan a wider field of candidates that fit different roles in your portfolio.
For investors hunting for mispriced opportunities with solid fundamentals, start with a focused 32 high quality undervalued stocks that match quality metrics with compressed valuations.
If resilience matters more than excitement, filter for companies with steadier risk profiles using a 29 resilient stocks with low risk scores that score well on financial health and earnings stability checks.
When you want to prioritize financial strength and durability, narrow your watchlist to a list of solid balance sheet and fundamentals (23 results) that can better handle industry or macro shocks.
This article is general in nature and was produced with the assistance of AI automation, based on data and analysis from Simply Wall St. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include DD.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
